Greenland Mines Ltd has recently disclosed a significant ownership change through a filing made on November 10, 2026. AnorTech Inc. now holds 9.8% of the company's common stock, a move that may influence future strategic decisions within the company.

Greenland Mines Ltd operates in the biological products sector, specifically categorized under the SIC description 'Biological Products, (No Diagnostic Substances).' The company trades on the Nasdaq under the tickers GRML and GRMLW. This filing follows a series of recent filings, including an 8-K on November 12, 2026.

The Schedule 13G filing indicates that AnorTech Inc. beneficially owns 1,451,268 shares of Greenland Mines Ltd, which represents a substantial stake in the company. The filing states, "The percentage set forth in Row 11 is calculated based on (i) 13,685,941 shares of common stock ('Common Shares') of Greenland Mines Inc. issued and outstanding as of October 23, 2026, and (ii) an additional 1,133,268 Common Shares issued by the Issuer to the reporting person on November 6, 2026." This acquisition positions AnorTech as a notable stakeholder in Greenland Mines Ltd.

This development may affect various stakeholders, including existing shareholders and competitors in the biological products industry. The increased ownership by AnorTech could lead to shifts in governance or strategic direction for Greenland Mines, potentially impacting its market position.

Details were not available in the SEC filing regarding what happens next. However, the significant stake held by AnorTech Inc. suggests that future developments may be closely monitored by industry analysts and competitors alike.